Literature DB >> 11179645

Diagnosis of ovine enzootic abortion using an indirect ELISA (rOMP91B iELISA) based on a recombinant protein fragment of the polymorphic outer membrane protein POMP91B of Chlamydophila abortus.

D Longbottom1, E Psarrou, M Livingstone, E Vretou.   

Abstract

Chlamydophila abortus is of major economic importance worldwide as one of the principal causes of abortion in sheep. Serological diagnosis of infection by the complement fixation test (CFT) is complicated by false positive reactions resulting from cross-reactive antibodies to Chlamydophila pecorum. To improve diagnosis an indirect enzyme-linked immunosorbent assay (iELISA) based on a recombinant protein fragment of the C. abortus polymorphic outer membrane protein POMP91B (rOMP91B iELISA) was assessed using a panel of 281 sera from experimentally and naturally infected sheep. The iELISA performed well, being more sensitive (84.2%) and specific (98.5%) than the CFT. Furthermore, the iELISA was better at differentiating C. abortus- from C. pecorum-infected animals. The new rOMP91B iELISA test will prove a valuable tool for the routine serodiagnosis of C. abortus infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179645     DOI: 10.1111/j.1574-6968.2001.tb10514.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  9 in total

1.  Serological diagnosis of ovine enzootic abortion by enzyme-linked immunosorbent assay with a recombinant protein fragment of the polymorphic outer membrane protein POMP90 of Chlamydophila abortus.

Authors:  David Longbottom; Susan Fairley; Stephanie Chapman; Evgenia Psarrou; Evangelia Vretou; Morag Livingstone
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Antibody responses to recombinant protein fragments of the major outer membrane protein and polymorphic outer membrane protein POMP90 in Chlamydophila abortus-infected pregnant sheep.

Authors:  Morag Livingstone; Gary Entrican; Sean Wattegedera; David Buxton; Iain J McKendrick; David Longbottom
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

Review 3.  Recent advances and public health implications for environmental exposure to Chlamydia abortus: from enzootic to zoonotic disease.

Authors:  Lauretta Turin; Sara Surini; Nick Wheelhouse; Mara Silvia Rocchi
Journal:  Vet Res       Date:  2022-05-31       Impact factor: 3.829

4.  Chlamydophila felis CF0218 is a novel TMH family protein with potential as a diagnostic antigen for diagnosis of C. felis infection.

Authors:  Kenji Ohya; Yu Takahara; Etsuko Kuroda; Saori Koyasu; Shigeyuki Hagiwara; Maki Sakamoto; Mitsuaki Hisaka; Kazuko Morizane; Shinryou Ishiguro; Tsuyoshi Yamaguchi; Hideto Fukushi
Journal:  Clin Vaccine Immunol       Date:  2008-09-03

5.  Antigenic organization of the N-terminal part of the polymorphic outer membrane proteins 90, 91A, and 91B of Chlamydophila abortus.

Authors:  Evangelia Vretou; Panagiota Giannikopoulou; David Longbottom; Evgenia Psarrou
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

6.  Immune response to Chlamydophila abortus POMP91B protein in the context of different Pathogen Associated Molecular Patterns (PAMP); role of antigen in the orientation of immune response.

Authors:  Vincent Le Moigne; Georges Robreau; Wahib Mahana
Journal:  Toxins (Basel)       Date:  2009-10-13       Impact factor: 4.546

7.  Comparison of three commercial serological tests for the detection of Chlamydia abortus infection in ewes.

Authors:  L M O'Neill; Á O'Driscoll; B Markey
Journal:  Ir Vet J       Date:  2018-05-29       Impact factor: 2.146

8.  Isolation and Identification of Chlamydia abortus from Aborted Ewes in Sulaimani Province, Northern Iraq.

Authors:  Eman Dhahir Arif; Nahla Muhammad Saeed; Shwan Kamal Rachid
Journal:  Pol J Microbiol       Date:  2020

9.  Chlamydophila abortus pelvic inflammatory disease.

Authors:  Gernot Walder; Herwig Meusburger; Helmut Hotzel; Albrecht Oehme; Walter Neunteufel; Manfred P Dierich; Reinhard Würzner
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.